Pharmacological Analysis of Mast Cell Mediator and Neurotransmitter Receptors Coupled to Adenylate Cyclase and Phospholipase C on Immunocytochemically-Defined Human Conjunctival Epithelial Cells

1997 ◽  
Vol 13 (4) ◽  
pp. 321-336 ◽  
Author(s):  
N.A. SHARIF ◽  
J.Y. CRIDER ◽  
B.W. GRIFFIN ◽  
T.L. DAVIS ◽  
W.E. HOWE
Cephalalgia ◽  
2012 ◽  
Vol 32 (4) ◽  
pp. 337-345 ◽  
Author(s):  
Michael Baun ◽  
Martin Holst Friborg Pedersen ◽  
Jes Olesen ◽  
Inger Jansen-Olesen

Background: Pituitary adenylate cyclase activating peptide-38 (PACAP-38) has been shown to induce migraine in migraineurs, whereas the related peptide vasoactive intestinal peptide (VIP) does not. In the present study we examine the hypothesis that PACAP-38 and its truncated version PACAP-27 but not VIP cause degranulation of mast cells in peritoneum and in dura mater. Methods: The degranulatory effects of PACAP-38, PACAP-27 and VIP were investigated by measuring the amount of N-acetyl-β-hexosaminidase released from isolated peritoneal mast cells and from dura mater attached to the skull of the rat in vitro. In peritoneal mast cells N-truncated fragments of PACAP-38 (PACAP(6–38), PACAP(16–38) and PACAP(28–38)) were also studied. To investigate transduction pathways involved in mast cell degranulation induced by PACAP-38, PACAP-27 and VIP, the phospholipase C inhibitor U-73122 and the adenylate cyclase inhibitor SQ 22536 were used. Results: The peptides induced degranulation of isolated peritoneal mast cells of the rat with the following order of potency: PACAP-38 = PACAP(6–38) = PACAP(16–38) » PACAP-27 = VIP = PACAP(28–38). In the dura mater we found that 10−5 M PACAP-38 was significantly more potent in inducing mast cell degranulation than the same concentration of PACAP-27 or VIP. Inhibition of intracellular mechanisms demonstrated that PACAP-38-induced degranulation is mediated by the phospholipase C pathway. Selective blockade of the PAC1 receptor did not attenuate degranulation. Conclusion: These findings correlate with clinical studies and support the hypothesis that mast cell degranulation is involved in PACAP-induced migraine. PACAP-38 has a much stronger degranulatory effect on rat peritoneal and dural mast cells than VIP and PACAP-27. The difference in potency between PACAP-38- and PACAP-27/VIP-induced peritoneal mast cell degranulation is probably not related to the PAC1 receptor but is caused by a difference in efficacy on phospholipase C.


2021 ◽  
Vol 20 ◽  
pp. 195-198
Author(s):  
Katerina Jirsova ◽  
Viera Vesela ◽  
Pavlina Skalicka ◽  
Eva Ruzickova ◽  
Johana Glezgova ◽  
...  

Nature ◽  
10.1038/38508 ◽  
1997 ◽  
Vol 389 (6648) ◽  
pp. 290-293 ◽  
Author(s):  
Daesoo Kim ◽  
Ki Sun Jun ◽  
Seong Beom Lee ◽  
Nae-Gyu Kang ◽  
Do Sik Min ◽  
...  

2011 ◽  
Vol 51 (5) ◽  
pp. 305-312 ◽  
Author(s):  
Victoria Hritonenko ◽  
James J. Mun ◽  
Connie Tam ◽  
Nathan C. Simon ◽  
Joseph T. Barbieri ◽  
...  

Allergy ◽  
2018 ◽  
Author(s):  
Xiaoying Zhou ◽  
Tao Wei ◽  
Christopher W. Cox ◽  
Andrew F. Walls ◽  
Yuan Jiang ◽  
...  

2006 ◽  
Vol 1760 (7) ◽  
pp. 1102-1108 ◽  
Author(s):  
Vasantha L. Kolachala ◽  
Tracy Sitler Obertone ◽  
Lixin Wang ◽  
Didier Merlin ◽  
Shanthi V. Sitaraman

Sign in / Sign up

Export Citation Format

Share Document